Poolbeg Pharma plc (“Poolbeg” or the “Company”) Combination of Poolbeg and HOOKIPA Pharma Inc.
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 02 2025
0mins
Source: Yahoo Finance
Potential Acquisition Announcement: Poolbeg Pharma plc and HOOKIPA Pharma Inc. have entered non-binding discussions for an all-share acquisition, aiming to create a combined clinical-stage biopharmaceutical company focused on innovative cancer immunotherapies and other serious diseases.
Ownership Structure and Future Plans: Under the proposed terms, Poolbeg shareholders would receive 0.03 HOOKIPA shares per Poolbeg share, resulting in approximately 55% ownership for Poolbeg shareholders in the new entity, which plans to conduct a $30 million fundraising to support its clinical programs.
Discover Tomorrow's Bullish Stocks Today
Receive free daily stock recommendations and professional analysis to optimize your portfolio's potential.
Sign up now to unlock expert insights and stay one step ahead of the market trends.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
